Alkermes Plc Net Income per Employee (ALKS), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Alkermes Plc   (NASDAQ: ALKS)
 

Alkermes Plc Net Income per Employee

ALKS's Quarterly Results, Trends, Rankings, Statistics
Alkermes Plc 's Income per employee fell in the second quarter 2026 on a trailing twelve month basis to $ 32,255, but the productivity of Alkermes Plc 's 2,050 employees remained above the company average.
The Healthcare sector has seen employees of 55 other companies achieving higher income per employee. While Alkermes Plc 's total ranking has deteriorated compared to the previous quarter from 1104 to 1131.


What is Income per Employee Ratio?






ALKS Net Income per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Net Income Change -99.42 % - -66.32 % -10.41 % -4.66 %
Net Income per Employee (TTM) $ 32,255 74,498 117,885 165,281 169,974
ALKS's Total Ranking # 1131 # 1104 # 692 # 533 # 406
Seq. Net Income Change - - -40.38 % -4.98 % 287.72 %


ALKS Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 56
Healthcare Sector # 100
Overall Market # 1131

Net Income per Employee Statistics
High Average Low
$ 211,917 $ -12,697 $ -134,153
(Mar 31 2024)   (Jun 30 2016)







Companies with similar Income per Employee for 12 month ending Jun 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2026Number of Employees Jun 30 2026
Medtronic Plc  55,463.16 $ 5,269.000  Million 95,000 
Mettler toledo International Inc   54,554.88 $ 905.611  Million 16,600 
Sotera Health Company  54,493.00 $ 163.479  Million 3,000 
West Pharmaceutical Services Inc   52,305.56 $ 564.900  Million 10,800 
3m Company  49,785.12 $ 3,012.000  Million 60,500 
Nephros Inc   48,222.22 $ 1.736  Million 36 
Cormedix Inc   47,794.66 $ 9.129  Million 191 
Embecta Corp   47,297.30 $ 87.500  Million 1,850 
Qhslab Inc   43,675.67 $ 0.524  Million 12 
Merck and Co Inc   42,266.67 $ 3,170.000  Million 75,000 
Phibro Animal Health Corporation  38,280.23 $ 99.720  Million 2,605 
Arvinas Inc   37,804.88 $ 9.300  Million 246 
Alkermes Plc   32,255.12 $ 66.123  Million 2,050 
Tenet Healthcare Corp  32,060.61 $ 3,174.000  Million 99,000 
Haemonetics Corporation  31,851.47 $ 96.287  Million 3,023 
Pacific Health Care Organization Inc  31,571.29 $ 0.979  Million 31 
Bio rad Laboratories Inc   29,852.35 $ 222.400  Million 7,450 
Privia Health Group Inc   27,598.69 $ 33.836  Million 1,226 
Pediatrix Medical Group Inc   26,667.58 $ 174.806  Million 6,555 
Amneal Pharmaceuticals Inc   25,331.65 $ 215.319  Million 8,500 
Nature s Sunshine Products inc   23,205.96 $ 18.704  Million 806 
Tactile Systems Technology Inc   22,895.95 $ 24.865  Million 1,086 
Lifevantage Corp  22,744.39 $ 5.072  Million 223 
Biomarin Pharmaceutical Inc  22,655.08 $ 72.972  Million 3,221 
Revvity Inc  21,595.82 $ 237.554  Million 11,000 
Waters Corporation  21,030.00 $ 166.137  Million 7,900 
Teva Pharmaceutical Industries Limited  20,883.65 $ 709.000  Million 33,950 
Repligen Corp  20,769.50 $ 41.539  Million 2,000 
Encompass Health Corporation  19,840.48 $ 833.300  Million 42,000 
Quest Diagnostics Inc  19,526.32 $ 1,113.000  Million 57,000 


Date modified: 2026-07-29T06:45:55+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.